Skip to main content
Figure 1 | Critical Care

Figure 1

From: Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials

Figure 1

Trial profile. The figure shows the number of penetrating and blunt trauma patients eligible in the two groups (placebo and recombinant activated factor VII [rFVIIa]), the exclusion of patients because of traumatic brain injury (TBI) and insufficient data concerning the coagulopathic state, and the number of patients finally adjudicated to the placebo and rFVIIa analysis. RBC, red blood cells.

Back to article page

Critical Care

ISSN: 1364-8535